Form 4: Newmont Executive Sells 8,060 Shares Under 10b5-1 Plan
Insider Transaction Report
Newmont's MD, Americas, David John Thornton, sold 8,060 shares of common stock for $120.78 per share as part of a pre-arranged trading plan.
Summary
- David John Thornton, Newmont Corp's MD, Americas, reported a sale of common stock.
- The transaction involved the disposition of 8,060 shares of Common Stock, $1.60 par value.
- The shares were sold at a price of $120.78 per share.
- The sale was executed on March 3, 2026.
- Following this transaction, Mr. Thornton beneficially owns 27,264 shares of Newmont common stock directly.
- The sale was conducted pursuant to a Rule 10b5-1 trading plan, which was dated December 1, 2025.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The sale was conducted under a pre-arranged 10b5-1 plan, which typically indicates a planned personal financial move rather than a reaction to new company-specific information, thus having minimal impact on sentiment.
Positives
- The sale was executed under a Rule 10b5-1 trading plan, indicating a pre-planned transaction for diversification or liquidity rather than a reaction to new negative information.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding Newmont's future performance or outlook.
Industry Context
StockSavvy.ai notes that insider sales, particularly those executed under a Rule 10b5-1 trading plan, are a common practice for executives to manage personal finances, diversify holdings, or meet liquidity needs. Such transactions are generally pre-scheduled and do not typically reflect a change in the executive's view of the company's immediate prospects or broader industry trends.
Stakeholder Impact
- Shareholders: Minimal direct impact as the sale is a routine insider transaction under a pre-arranged plan, not indicative of a change in company fundamentals.
Key Dates
| Date | Description |
|---|---|
| 12/01/2025 | Date of the Rule 10b5-1 trading plan. |
| 03/03/2026 | Date of the reported transaction (sale of common stock). |
| 03/04/2026 | Date the Form 4 was signed. |
Recommendation
holdThe sale by a Newmont executive was executed under a pre-arranged 10b5-1 trading plan, indicating a planned diversification or liquidity event rather than a reaction to new material information. This type of transaction is generally considered neutral and does not typically warrant a change in investment recommendation based solely on this filing.
Keywords
Newmont, NEM, Insider Trading, Form 4, Stock Sale, David John Thornton, Officer Transaction, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.